Home Ā» Knowledge Center Ā» A multifaceted study of X-Ray radiation therapy across diverse mouse tumor modelsĀ
A multifaceted study of X-Ray radiation therapy across diverse mouse tumor modelsĀ
Although radiation contributes to approximately 40% of all cancer treatment regimens globally, preclinical programs to evaluate its capacity in combination with chemotherapy or immunotherapy are lacking. At Pharmaron, we provide a platform featuring highly precise x-ray radiation therapy for small animal to identify novel radiosensitizers as well as understand effects of radiation in combination with new drug candidates. This research will further strengthen the role of radiation oncology.